Physician profile
Eric S Molho
NPI 1427042399
$43,586.90
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $7,058 · 2021: $18K · 2022: $2,690 · 2023: $3,338 · 2024: $1,800.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,250 · Education: $1,517 · Food and Beverage: $215 · Travel and Lodging: $156.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,250.00 |
| Education | $1,516.88 |
| Food and Beverage | $215.16 |
| Travel and Lodging | $155.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $35,528.67 | 2019-2024 | |
| Acadia Pharmaceuticals INC | $3,337.72 | 2023 | Nuplazid |
| Lundbeck LLC | $2,475.00 | 2020 | |
| Amneal Pharmaceuticals LLC | $1,500.00 | 2024 | |
| Ucb Sa | $569.69 | 2022 | |
| Stryker Corporation | $96.54 | 2021 | |
| Genzyme Corporation | $79.28 | 2019 |
6 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Molho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.